We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$8.1B
AUM Growth
+$4.9B
Cap. Flow
+$4.22B
Cap. Flow %
52.11%
Top 10 Hldgs %
26.76%
Holding
6,444
New
505
Increased
3,426
Reduced
1,637
Closed
524

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$314M
2
AAPL icon
Apple
AAPL
+$247M
3
MSFT icon
Microsoft
MSFT
+$235M
4
AMZN icon
Amazon
AMZN
+$110M
5
NVDA icon
NVIDIA
NVDA
+$99M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$21.7M
2
VNQ icon
Vanguard Real Estate ETF
VNQ
+$13.8M
3
SPLV icon
Invesco S&P 500 Low Volatility ETF
SPLV
+$12.8M
4
USO icon
United States Oil Fund
USO
+$12.5M
5
IBB icon
iShares Biotechnology ETF
IBB
+$12M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Financials 11.29%
3 Healthcare 10.69%
4 Consumer Discretionary 10.28%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBCAA icon
3526
Republic Bancorp
RBCAA
$1.93B
$24.8K ﹤0.01%
449
-70
-13% -$3.33K
MLYS icon
3527
Mineralys Therapeutics
MLYS
$2.26B
$24.8K ﹤0.01%
2,879
-7,181
-71% -$56.4K
MFG icon
3528
Mizuho Financial
MFG
$132B
$24.7K ﹤0.01%
+7,180
New +$24.4K
FULC icon
3529
Fulcrum Therapeutics
FULC
$285M
$24.7K ﹤0.01%
3,658
-1,589
-30% -$7.05K
FTSM icon
3530
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
$24.6K ﹤0.01%
413
-70
-14% -$4.17K
STLN
3531
Starling Oncology, Inc. Common Stock
STLN
$659M
$24.6K ﹤0.01%
+12,046
New +$20.9K
API
3532
Agora
API
$390M
$24.5K ﹤0.01%
9,333
-67
-0.7% -$187
YGF
3533
DELISTED
YanGuFang International Group Co., Ltd. Ordinary Shares
YGF
$24.5K ﹤0.01%
8,610
+8,557
+16,145% +$26.1K
LXRX icon
3534
Lexicon Pharmaceuticals
LXRX
$1.03B
$24.4K ﹤0.01%
15,921
-1,009
-6% -$1.2K
SCO icon
3535
ProShares UltraShort Bloomberg Crude Oil
SCO
$599M
$24.4K ﹤0.01%
292
-6,125
-95% -$463K
ADCT icon
3536
ADC Therapeutics
ADCT
$130M
$24.3K ﹤0.01%
14,641
+10,521
+255% +$9.71K
QDF icon
3537
FlexShares Quality Dividend Index Fund
QDF
$2.28B
$24.3K ﹤0.01%
395
+342
+645% +$19.8K
ATOM icon
3538
Atomera
ATOM
$221M
$24.2K ﹤0.01%
3,456
-6,595
-66% -$43.8K
VNQ icon
3539
Vanguard Real Estate ETF
VNQ
$39.3B
$24.2K ﹤0.01%
274
-174,229
-100% -$13.8M
CZFS icon
3540
Citizens Financial Services
CZFS
$399M
$24.2K ﹤0.01%
382
-387
-50% -$20.8K
DFAC icon
3541
Dimensional US Core Equity 2 ETF
DFAC
$49.9B
$24.2K ﹤0.01%
828
-427
-34% -$11.6K
TASK icon
3542
TaskUs
TASK
$683M
$24.1K ﹤0.01%
1,847
-3,203
-63% -$35.5K
COOK icon
3543
Traeger
COOK
$167M
$24.1K ﹤0.01%
177
+68
+62% +$8.78K
FOSL icon
3544
Fossil Group
FOSL
$323M
$24K ﹤0.01%
16,462
+12,947
+368% +$19K
SNBR
3545
DELISTED
Sleep Number
SNBR
$24K ﹤0.01%
1,616
+534
+49% +$8.29K
FEIM icon
3546
Frequency Electronics
FEIM
$856M
$23.9K ﹤0.01%
2,182
-310
-12% -$2.67K
MCBC
3547
DELISTED
Macatawa Bank Corp
MCBC
$23.8K ﹤0.01%
2,112
-480
-19% -$4.69K
ALX
3548
Alexander's
ALX
$1.4B
$23.7K ﹤0.01%
111
-83
-43% -$15.7K
TMV icon
3549
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$196M
$23.7K ﹤0.01%
800
+794
+13,233% +$32.6K
COFS icon
3550
Choiceone Financial
COFS
$516M
$23.6K ﹤0.01%
807
-11
-1% -$257
140 141
142
143 144

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2023 Portfolio in Review

As of Q4 2023, Tower Research Capital (TRC) held 6,444 positions worth $8.1B, up 153% from $3.2B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $4.22B of net new capital in Q4 2023, opening 505 new positions and adding to 3,426 existing holdings. Its largest new stake was Veralto: 28,523 shares worth $2.35M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $21.7M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2023 buy was Veralto: 28,523 shares worth $2.35M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $314M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2023 reduction was iShares MSCI EAFE ETF, cutting an estimated $21.7M.
  • Tower Research Capital (TRC) fully exited Vanguard Morningstar Total Stock Market ETF in Q4 2023, selling an estimated $6.02M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $8.1B portfolio in Q4 2023.
  • Tower Research Capital (TRC) opened 505 new positions and closed 524 in Q4 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 153% quarter-over-quarter to $8.1B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.